Início › Câncer de Rim (Carcinoma de Células Renais) › Califórnia

Ensaios clínicos de Câncer de Rim (Carcinoma de Células Renais) em Califórnia

51 estudos para Câncer de Rim (Carcinoma de Células Renais) estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Research Site, San Diego
Research Site, Santa Monica

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NEO-811 Los Angeles Site, Duarte
NEO-811 San Diego Site, San Diego

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de out. de 2026 · NCT07300241

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

UCSF Medical Center at Mission Bay ( Site 5008), San Francisco

RecrutandoFase 1/2

Idades de 18 a 120 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07049926

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of California San Diego Moores Cancer Center, La Jolla
Cedars-Sinai Medical Center, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06234605

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
e mais 20

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #59, Santa Barbara

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05176483

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

University of California Irvine, Orange
Stanford, Palo Alto
University of California San Francisco, San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05287945

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
e mais 1

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

City of Hope, Duarte

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07594106

DESTINY-PANTUMOUR04

Research Site, San Diego

RecrutandoEstudo observacional

Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

University of California San Diego, La Jolla
Stanford University, Palo Alto
UCLA Medical Center, Santa Monica

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04981119

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Local Institution - 0178, Palo Alto

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07293351

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

University of California San Diego, La Jolla

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

PCR Oncology, Arroyo Grande
Tower Cancer Research Foundation, Beverly Hills
Mills-Peninsula Medical Center, Burlingame
e mais 16

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
City of Hope Investigational Drug Services (IDS), Duarte
UC San Diego Medical Center - Encinitas, Encinitas
e mais 13

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT07227415

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

USC Norris Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04969315

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

City of Hope Medical Center, Duarte
University of California San Diego Medical Center, Moores Cancer Center, La Jolla

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

University of California, San Diego, La Jolla
Hoag Memorial Hospital Presbyterian, Newport Beach
Redwood City, Redwood City

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Sutter Auburn Faith Hospital, Auburn
Tower Cancer Research Foundation, Beverly Hills
City of Hope Comprehensive Cancer Center, Duarte
e mais 23

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06661720

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT05830058

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

University of Southern California, Los Angeles
Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
Cedars-Sanai Medical Center, Los Angeles
e mais 1

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT06582017

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06432036

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

City of Hope National Medical Center, Duarte
Chao Family Comprehensive Cancer Center, Orange

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT05361720

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Community Cancer Institute, Clovis
USC/Norris Comprehensive Cancer Center, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04895709

A Study of MGC026 in Participants With Advanced Solid Tumors

The Angeles Clinic and Research Institute, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

City of Hope Medical Center, Duarte

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07226544

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Providence Medical Foundation ( Site 0141), Fullerton
USC Norris Comprehensive Cancer Center ( Site 0126), Los Angeles
Cedars-Sinai Medical Center ( Site 0112), Los Angeles

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT07227402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Duarte
Xencor Investigative Site, Sacramento

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

City of Hope, Duarte
Los Angeles Cancer Network, Glendale
California Research Institute, Los Angeles
e mais 3

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

University of California, San Francisco, San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT07043608

Imaging of Solid Tumors Using 18F-TRX

University of California, San Francisco, San Francisco

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT06942104

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

City of Hope Medical Center, Duarte
City of Hope Medical Center, Irvine

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT07128680

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

John Wayne Cancer Institute (JWCI), Santa Monica

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT03972657

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

University of California, Davis, Sacramento

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06101290

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT06447103

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Start Lacn, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT07517198

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

City of Hope Medical Center, Duarte
City of Hope at Irvine Lennar, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jun. de 2026 · NCT07037004

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

University of Southern California, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
UCLA Department of Medicine, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT06026410

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

City of Hope, Irvine

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 20 de mai. de 2026 · NCT06053658

Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.